Brian Atwood(4)

Photo of Brian Atwood, Versant Ventures
CompanyDeal TypeAmountDate
Immune DesignSeries C$49MOct 2013
VeracyteSeries C$28MJun 2013
Five Prime TherapeuticsPrivate Equity Round$10MApr 2012
OpGenSeries C$17MMar 2012
Groove BiopharmaSeries B$6MDec 2011
OpGenSeries B$17MSep 2010
Immune DesignSeries B$32MJul 2010
VeracyteSeries B$28MJun 2010
Groove BiopharmaSeries A$3.9MApr 2010
Immune DesignSeries A$18MJul 2008
No media found for Brian Atwood.
cb
Photo of Barbara Lubash, Versant Ventures

Versant Ventures

Photo of Beckie Robertson, Versant Ventures

Versant Ventures

Photo of Bill Link, Managing Partner at Versant Ventures

Versant Ventures

Photo of Brad Bolzon, Managing Partner at Versant Ventures

Versant Ventures

Photo of Cameron Pitt, Versant Ventures

Versant Ventures